Insmed to Present at the Deutsche Bank 42nd Annual Health Care Conference
27. April 2017 07:00 ET
|
Insmed Incorporated
BRIDGEWATER, N.J., April 27, 2017 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, announced today...
Insmed to Host First Quarter 2017 Financial Results Conference Call on Wednesday, May 3, 2017
26. April 2017 07:00 ET
|
Insmed Incorporated
BRIDGEWATER, N.J., April 26, 2017 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced...
Insmed to Present at the Cowen and Company 37th Annual Health Care Conference
28. Februar 2017 08:00 ET
|
Insmed Incorporated
BRIDGEWATER, N.J., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, announced...
Insmed Reports Fourth Quarter 2016 Financial Results and Provides Business Update
23. Februar 2017 08:02 ET
|
Insmed Incorporated
On Track to Report Top-Line Results from CONVERT Study in 2H 2017 Conference call today at 8:30 AM ET BRIDGEWATER, N.J., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Insmed...
Insmed to Host Fourth Quarter and Year-end 2016 Financial Results Conference Call on Thursday, February 23, 2017
16. Februar 2017 07:00 ET
|
Insmed Incorporated
BRIDGEWATER, N.J., Feb. 16, 2017 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced...
Insmed Inc. Extends ARIKAYCE Intellectual Property Protection with Issuance of New U.S. Patent
14. Februar 2017 08:05 ET
|
Insmed Incorporated
BRIDGEWATER, N.J., Feb. 14, 2017 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced...
Insmed to Present at the 35th Annual J.P. Morgan Healthcare Conference
04. Januar 2017 08:00 ET
|
Insmed Incorporated
BRIDGEWATER, N.J., Jan. 04, 2017 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today reported...
Insmed to Participate at November Investor Conferences
14. November 2016 08:00 ET
|
Insmed Incorporated
BRIDGEWATER, N.J., Nov. 14, 2016 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today reported...
Insmed Reports Third Quarter 2016 Financial Results and Provides Business Update
03. November 2016 08:02 ET
|
Insmed Incorporated
Enrollment objective achieved in phase 3 CONVERT study Conference call today at 8:30 AM ET BRIDGEWATER, N.J., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global...
Insmed to Host Third Quarter 2016 Financial Results Conference Call on Thursday, November 3, 2016
27. Oktober 2016 08:00 ET
|
Insmed Incorporated
BRIDGEWATER, N.J., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the needs of patients with rare diseases, today announced that...